Dusquetide aceate is an innate immune defense regulator against damage-associated molecular patterns and pathogen-associated molecular patterns. Dusquetide aceate shows anti-inflammation and antibacterial activities.
Dusquetide aceate (25 mg/kg; i.v.) shows a trend towards decreased tumor growth and improvement in survival with radiation with no increase in tumor growth or worsening of survival[1].